This follows Sun Pharma's recent recall of 54,960 bottles of Mesalamine extended-release capsules in the American market. Mesalamine delayed-release capsules are indicated for the treatment of ...

Gujarat: TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited, has entered into an agreement with ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 2.01% to 1,834.05 Indian rupees Thursday, on what proved to be ...

In the same year, Sun Pharma opened its first manufacturing facility for the production of tablets and capsules at Vapi, Gujarat, India. Initially, the company manufactured five psychiatry products.

Sun Pharmaceutical Industries share price gained in the early trade on January 1 after the company is going to sell its entire holding in Japanese subsidiary. At 09:26am, Sun Pharmaceutical ...